Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 155

1.

Small-particle Inhaled Corticosteroid as First-line or Step-up Controller Therapy in Childhood Asthma.

van Aalderen WM, Grigg J, Guilbert TW, Roche N, Israel E, Martin RJ, Colice G, Postma DS, Hillyer EV, Burden A, Thomas V, von Ziegenweidt J, Price D.

J Allergy Clin Immunol Pract. 2015 May 29. pii: S2213-2198(15)00240-8. doi: 10.1016/j.jaip.2015.04.012. [Epub ahead of print]

2.

Differential effects of inhaled corticosteroids in smokers/ex-smokers and nonsmokers with asthma.

Roche N, Postma DS, Colice G, Burden A, Guilbert TW, Israel E, Martin RJ, van Aalderen WM, Grigg J, Hillyer EV, von Ziegenweidt J, Price DB.

Am J Respir Crit Care Med. 2015 Apr 15;191(8):960-4. doi: 10.1164/rccm.201411-2116LE. No abstract available.

PMID:
25876207
3.

Increased Dose of Inhaled Corticosteroid versus Add-On Long-acting β-Agonist for Step-Up Therapy in Asthma.

Israel E, Roche N, Martin RJ, Colice G, Dorinsky PM, Postma DS, Guilbert TW, van Aalderen WM, Grigg J, Hillyer EV, Burden A, von Ziegenweidt J, Thomas V, Price DB.

Ann Am Thorac Soc. 2015 Jun;12(6):798-806. doi: 10.1513/AnnalsATS.201412-580OC.

PMID:
25756308
4.

Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD.

Postma DS, Roche N, Colice G, Israel E, Martin RJ, van Aalderen WM, Grigg J, Burden A, Hillyer EV, von Ziegenweidt J, Gopalan G, Price D.

Int J Chron Obstruct Pulmon Dis. 2014 Oct 17;9:1163-86. doi: 10.2147/COPD.S68289. eCollection 2014.

5.

Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study.

Martin RJ, Price D, Roche N, Israel E, van Aalderen WM, Grigg J, Postma DS, Guilbert TW, Hillyer EV, Burden A, von Ziegenweidt J, Colice G.

NPJ Prim Care Respir Med. 2014 Oct 9;24:14081. doi: 10.1038/npjpcrm.2014.81.

PMID:
25297072
6.

Response.

Colice GL, Idell S.

Chest. 2014 Sep;146(3):e104-5. doi: 10.1378/chest.14-0920. No abstract available.

PMID:
25180733
7.

A simple rule to identify patients with chronic obstructive pulmonary disease who may need treatment reevaluation.

Sharafkhaneh A, Altan AE, Colice GL, Hanania NA, Donohue JF, Kurlander JL, Rodriguez-Roisin R, Altman PR.

Respir Med. 2014 Sep;108(9):1310-20. doi: 10.1016/j.rmed.2014.07.002. Epub 2014 Jul 14.

PMID:
25130680
8.

Methicillin-resistant Staphylococcus aureus pneumonia in adults.

Woods C, Colice G.

Expert Rev Respir Med. 2014 Oct;8(5):641-51. doi: 10.1586/17476348.2014.940323. Epub 2014 Jul 17. Review.

PMID:
25030040
9.
10.

Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort.

Jones RC, Price D, Ryan D, Sims EJ, von Ziegenweidt J, Mascarenhas L, Burden A, Halpin DM, Winter R, Hill S, Kearney M, Holton K, Moger A, Freeman D, Chisholm A, Bateman ED; Respiratory Effectiveness Group.

Lancet Respir Med. 2014 Apr;2(4):267-76. doi: 10.1016/S2213-2600(14)70008-6. Epub 2014 Feb 13.

11.

Tiotropium in asthma: a systematic review.

Befekadu E, Onofrei C, Colice GL.

J Asthma Allergy. 2014 Feb 27;7:11-21. doi: 10.2147/JAA.S38841. eCollection 2014. Review.

12.

The effect of obesity on outcomes in mechanically ventilated patients in a medical intensive care unit.

Lee CK, Tefera E, Colice G.

Respiration. 2014;87(3):219-26. doi: 10.1159/000357317. Epub 2014 Jan 23.

PMID:
24457313
13.

Comparative effectiveness of intravenous and inhaled magnesium in acute asthma.

Colice GL.

J Comp Eff Res. 2013 Sep;2(5):437-41. doi: 10.2217/cer.13.55.

PMID:
24236741
14.

Results of the two incidence screenings in the National Lung Screening Trial.

Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gatsonis CA, Gierada DS, Jain A, Jones GC, Mahon I, Marcus PM, Rathmell JM, Sicks J; National Lung Screening Trial Research Team.

N Engl J Med. 2013 Sep 5;369(10):920-31. doi: 10.1056/NEJMoa1208962.

15.

Exercise-induced bronchospasm, asthma control, and obesity.

Ostrom NK, Parsons JP, Eid NS, Craig TJ, Stoloff S, Hayden ML, Colice GL.

Allergy Asthma Proc. 2013 Jul-Aug;34(4):342-8. doi: 10.2500/aap.2013.34.3674.

PMID:
23883598
16.

The misuse of asthma drugs.

Colice GL.

Expert Rev Respir Med. 2013 Jun;7(3):307-20. doi: 10.1586/ers.13.27. Review.

PMID:
23734651
17.

Results of initial low-dose computed tomographic screening for lung cancer.

National Lung Screening Trial Research Team, Church TR, Black WC, Aberle DR, Berg CD, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gierada DS, Jones GC, Mahon I, Marcus PM, Sicks JD, Jain A, Baum S.

N Engl J Med. 2013 May 23;368(21):1980-91. doi: 10.1056/NEJMoa1209120.

18.

Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone.

Colice G, Martin RJ, Israel E, Roche N, Barnes N, Burden A, Polos P, Dorinsky P, Hillyer EV, Lee AJ, Chisholm A, von Ziegenweidt J, Barion F, Price D.

J Allergy Clin Immunol. 2013 Jul;132(1):45-54. doi: 10.1016/j.jaci.2013.02.008. Epub 2013 Apr 13.

PMID:
23591272
19.

Inhaler devices for patients with COPD.

Fink JB, Colice GL, Hodder R.

COPD. 2013 Aug;10(4):523-35. doi: 10.3109/15412555.2012.761960. Epub 2013 Mar 28. Review.

PMID:
23537191
20.

Strategies for tailoring asthma treatment in adults.

Colice GL.

JAMA. 2013 Jan 9;309(2):136. doi: 10.1001/jama.2012.73382. No abstract available.

PMID:
23299597
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk